Friday, February 02, 2018 10:15 PM ET
Significant Insider Selling Continues at Biohaven Pharmaceutical Holding (BHVN)
An insider — Gregory Bailey, Director — sold 50,000 shares of Biohaven Pharmaceutical Holding having a market value of approximately $1,685,352 today, as revealed in a form 4 document filed with the SEC. There have been 4 insiders with buy/sell transactions in the past 90 days prior to this filing. All of these trades have been sales resulting in the sale of 884,927 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 934,927 shares and have averaged 186,985 shares per transaction over this time period.
During the last 90 days, the number of insider buy/sell trades at Biohaven Pharmaceutical Holding is greater than the 191-company peer group average. Biotechnology & Medical Research peer group saw 168 buy/sell trades during this period for an average of 0.9 transactions per company. The number of shares per buy/sell trade for Biohaven Pharmaceutical Holding insiders was also higher. Within the peer group there were 11,231,010 shares purchased and 12,764,114 shares sold with company insiders having sold 9,126 shares on average.
The data sourced in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.